Skip to content
10-Q

Quarterly Report

STEADYMED LTD.

0001104659-17-032132

← back to feed
Filed
May 12, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 12, 2017 25.17M sh
Cash And Equivalents Q1 2017 · Mar 31, 2017 $14.58M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $23.22M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $25.38M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $31.85M
Stockholders Equity Q1 2017 · Mar 31, 2017 −$4M
Stockholders Equity Q1 2017 · Dec 31, 2016 $14.31M
Current Liabilities Q1 2017 · Mar 31, 2017 $3.79M
Current Liabilities Q1 2017 · Dec 31, 2016 $6.36M
Current Assets Q1 2017 · Mar 31, 2017 $14.78M
Current Assets Q1 2017 · Dec 31, 2016 $23.38M
Total Assets Q1 2017 · Mar 31, 2017 $20.01M
Total Assets Q1 2017 · Dec 31, 2016 $28.16M
Net Income Q1 2017 · Mar 31, 2017 −$18.56M
Net Income Q1 2017 · Mar 31, 2016 −$6.27M
Capex Q1 2017 · Mar 31, 2016 $634K
Sga Expense Q1 2017 · Mar 31, 2016 $1.43M
Rd Expense Q1 2017 · Mar 31, 2016 $4.97M
Operating Income Q1 2017 · Mar 31, 2016 −$6.24M
Revenue Q1 2017 · Mar 31, 2016 $375K